大塚ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/11/10 | 4,518 | 4,574 | 4,506 | 4,562 | +29 | +0.6% | 689,900 |
| 2022/11/09 | 4,580 | 4,586 | 4,518 | 4,533 | -67 | -1.5% | 850,200 |
| 2022/11/08 | 4,581 | 4,624 | 4,575 | 4,600 | +52 | +1.1% | 1,223,600 |
| 2022/11/07 | 4,602 | 4,610 | 4,546 | 4,548 | -54 | -1.2% | 1,021,500 |
| 2022/11/04 | 4,605 | 4,659 | 4,577 | 4,602 | -66 | -1.4% | 1,253,400 |
| 2022/11/02 | 4,639 | 4,683 | 4,602 | 4,668 | +38 | +0.8% | 1,255,700 |
| 2022/11/01 | 4,654 | 4,689 | 4,614 | 4,630 | -136 | -2.9% | 1,268,800 |
| 2022/10/31 | 4,738 | 4,788 | 4,655 | 4,766 | +82 | +1.8% | 1,647,500 |
| 2022/10/28 | 4,671 | 4,725 | 4,653 | 4,684 | +7 | +0.1% | 3,895,000 |
| 2022/10/27 | 4,705 | 4,711 | 4,648 | 4,677 | -8 | -0.2% | 943,600 |
| 2022/10/26 | 4,602 | 4,705 | 4,592 | 4,685 | +107 | +2.3% | 1,011,200 |
| 2022/10/25 | 4,601 | 4,609 | 4,567 | 4,578 | +25 | +0.5% | 949,700 |
| 2022/10/24 | 4,648 | 4,649 | 4,543 | 4,553 | -48 | -1% | 817,600 |
| 2022/10/21 | 4,612 | 4,655 | 4,601 | 4,601 | -53 | -1.1% | 830,900 |
| 2022/10/20 | 4,642 | 4,677 | 4,634 | 4,654 | -26 | -0.6% | 896,100 |
| 2022/10/19 | 4,716 | 4,733 | 4,670 | 4,680 | -21 | -0.4% | 684,900 |
| 2022/10/18 | 4,746 | 4,746 | 4,681 | 4,701 | +48 | +1% | 1,040,300 |
| 2022/10/17 | 4,680 | 4,687 | 4,631 | 4,653 | -54 | -1.1% | 871,900 |
| 2022/10/14 | 4,663 | 4,735 | 4,621 | 4,707 | +114 | +2.5% | 1,302,500 |
| 2022/10/13 | 4,596 | 4,637 | 4,569 | 4,593 | -3 | -0.1% | 765,200 |
| 2022/10/12 | 4,600 | 4,631 | 4,584 | 4,596 | -1 | ±0% | 872,500 |
| 2022/10/11 | 4,614 | 4,634 | 4,561 | 4,597 | -59 | -1.3% | 1,137,100 |
| 2022/10/07 | 4,646 | 4,682 | 4,626 | 4,656 | -20 | -0.4% | 925,800 |
| 2022/10/06 | 4,702 | 4,724 | 4,658 | 4,676 | -12 | -0.3% | 838,700 |
| 2022/10/05 | 4,700 | 4,727 | 4,664 | 4,688 | -1 | ±0% | 974,300 |
| 2022/10/04 | 4,621 | 4,697 | 4,613 | 4,689 | +103 | +2.2% | 1,069,300 |
| 2022/10/03 | 4,574 | 4,586 | 4,521 | 4,586 | +2 | ±0% | 1,026,500 |
| 2022/09/30 | 4,612 | 4,640 | 4,557 | 4,584 | -3 | -0.1% | 1,759,100 |
| 2022/09/29 | 4,516 | 4,602 | 4,502 | 4,587 | +141 | +3.2% | 1,244,700 |
| 2022/09/28 | 4,428 | 4,455 | 4,398 | 4,446 | -22 | -0.5% | 1,536,500 |
| 2022/09/27 | 4,435 | 4,496 | 4,434 | 4,468 | +40 | +0.9% | 856,600 |
| 2022/09/26 | 4,421 | 4,456 | 4,400 | 4,428 | -42 | -0.9% | 1,301,900 |
| 2022/09/22 | 4,457 | 4,475 | 4,410 | 4,470 | -22 | -0.5% | 1,146,300 |
| 2022/09/21 | 4,508 | 4,524 | 4,474 | 4,492 | -54 | -1.2% | 773,200 |
| 2022/09/20 | 4,532 | 4,559 | 4,526 | 4,546 | +16 | +0.4% | 887,500 |
| 2022/09/16 | 4,500 | 4,546 | 4,492 | 4,530 | -2 | ±0% | 1,210,800 |
| 2022/09/15 | 4,534 | 4,541 | 4,499 | 4,532 | -7 | -0.2% | 621,300 |
| 2022/09/14 | 4,534 | 4,554 | 4,511 | 4,539 | -93 | -2% | 836,500 |
| 2022/09/13 | 4,658 | 4,669 | 4,628 | 4,632 | -11 | -0.2% | 555,500 |
| 2022/09/12 | 4,661 | 4,665 | 4,615 | 4,643 | -11 | -0.2% | 566,000 |
| 2022/09/09 | 4,602 | 4,679 | 4,599 | 4,654 | +55 | +1.2% | 1,347,900 |
| 2022/09/08 | 4,567 | 4,604 | 4,559 | 4,599 | +107 | +2.4% | 1,002,000 |
| 2022/09/07 | 4,547 | 4,560 | 4,453 | 4,492 | -35 | -0.8% | 1,008,700 |
| 2022/09/06 | 4,513 | 4,552 | 4,506 | 4,527 | +53 | +1.2% | 754,100 |
| 2022/09/05 | 4,466 | 4,497 | 4,440 | 4,474 | -62 | -1.4% | 840,300 |
| 2022/09/02 | 4,551 | 4,559 | 4,502 | 4,536 | +10 | +0.2% | 873,300 |
| 2022/09/01 | 4,530 | 4,552 | 4,520 | 4,526 | -35 | -0.8% | 660,400 |
| 2022/08/31 | 4,509 | 4,570 | 4,509 | 4,561 | +28 | +0.6% | 1,282,900 |
| 2022/08/30 | 4,555 | 4,586 | 4,528 | 4,533 | -17 | -0.4% | 677,300 |
| 2022/08/29 | 4,531 | 4,561 | 4,509 | 4,550 | -51 | -1.1% | 781,000 |
501～
550
件表示中 / 3412件
類似銘柄と比較する
現在ご覧いただいている「大塚ＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 大塚ＨＤ | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 第一三共 | 443,500円 | +14.3% | +20.1% | 1.35% | 37.27倍 | 5.17倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 411,300円 | +5.1% | +76.2% | 4.77% | 95.87倍 | 0.94倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム
